FUNMILOLA OLAOYE: Open Payments
NPI 1548903610 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 36 payments from 17 companies in 2025. Trend: 2023 $2,660 · 2024 $2,874 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 1 | $153 |
| Lilly USA, LLC | 7 | $136 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Exact Sciences Corporation | 2 | $50 |
| Amgen Inc. | 2 | $49 |
| Abbott Laboratories | 2 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $38 |
Products named: CeQur Simplicity, JARDIANCE, MOUNJARO, REXULTI, The Cologuard Plus Collection Kit, TEPEZZA, FREESTYLE LIBRE 3, UNITHROID.
Industry payments across DE — which companies pay providers there.
